Curious to see your top suppliers emissions?
Book a demo for a pilot project
Celgene Corporation
Pharmaceutical Preparation ManufacturingUnited States
Last verified 1 month ago
Celgene Corporation, a prominent player in the pharmaceutical preparation manufacturing industry, is headquartered in the United States. Founded in 1986, the company has made significant strides in developing innovative therapies, particularly in the fields of oncology and immunology. Celgene is renowned for its core products, including Revlimid and Pomalyst, which have transformed treatment protocols for various blood cancers.
With a strong presence in North America, Europe, and Asia, Celgene has established itself as a leader in the biopharmaceutical sector. The company’s commitment to research and development has led to numerous breakthroughs, positioning it as a key contributor to advancements in personalised medicine. Notable achievements include its acquisition by Bristol-Myers Squibb in 2019, further solidifying its market position and expanding its reach in the global healthcare landscape.
82
DitchCarbon score
+42 vs industry average
Celgene Corporation’s score of 82 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Celgene Corporation?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Celgene Corporation yet.
Celgene Corporation's reported carbon emissions
Celgene Corporation, a pharmaceutical preparation manufacturing company headquartered in the US, has a climate strategy that is influenced by its parent organisation, Bristol-Myers Squibb Company.
As no direct emissions data for Celgene Corporation is available, their climate commitments and reporting are cascaded from Bristol-Myers Squibb Company. Bristol-Myers Squibb Company provides the emissions data for Celgene Corporation, which is at cascade level 1.
Information regarding specific reduction targets or achievements for Celgene Corporation is not provided. However, as part of Bristol-Myers Squibb Company, Celgene Corporation's environmental performance is integrated into the broader corporate sustainability framework. The Science Based Targets initiative (SBTi) targets for Celgene Corporation are also cascaded from Bristol-Myers Squibb Company. Further details on climate initiatives and emissions reductions are available through Bristol-Myers Squibb Company's reporting.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Celgene Corporation’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Celgene Corporation yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Bristol-Myers Squibb CompanySee details
Not active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
Inherited from Bristol-Myers Squibb CompanySee details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Celgene Corporation yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more